Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04764448
Status:
TERMINATED
Last Update Posted:
2024-07-12
First Post:
2021-01-27
Brief Title:
A Study of Belcesiran in Patients With AATLD
Sponsor:
Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Alpha 1-Antitrypsin Deficiency |
Keywords: